Silver Bullet Therapeutics Grows IP Portfolio
Silver Bullet Therapeutics was allowed a U.S. patent, "Bone Implants for the Treatment of Infection." Feb 16, 2016
Study results: Episealer may stop or significantly slow the process leading to OA
Study results suggest that a permanent bond may form between cartilage and the hydroxyapatite coating of Episurf’s Episealer® device, suggesting that implantation may stop or significantly slow the progression to OA. Feb 15, 2016
Strategic Orthopaedic-related 510(k)s issued in January 2016
Strategic orthopaedic-related 510(k)s issued in January 2016 include: Half Dome PLIF System (Astura Medical*), Cannulated Screw System (Epic Extremity*), Rosa Spine (Medtech*), IFS Fixation Scaffold (Metric Medical), dynaMX MX Tabbed Staple (MX Orthopedics), Hard Carbon Coated Drill Bit (Renovo Life*), Polyscrew Pedicle Fixation System (Senecka Spine*), Interbody System (Spine Innovation*), VerteLP IBF Device (VGI Medical*) Feb 12, 2016
Medline Expands its Foot/Ankle trauma Portfolio
Medline launched the UNITE® Foot Plating system, ARROW-LOK® Digital Fusion system and DBM putty/demineralized cancellous sponge products. Feb 12, 2016
Zimmer Biomet Receives FDA 510(k) Clearance for Unite3D Bridge Fixation System
Zimmer Biomet received FDA 510(k) clearance for the Unite3D™ Bridge Fixation System, 3D-printed technology designed for use in foot and ankle arthrodesis. Feb 12, 2016
RTI Surgical to License OPM’s OsteoFab 3D Printing Technology
RTI Surgical entered into an agreement with Oxford Performance Materials, gaining exclusive license for use of OsteoFab® additive manufacturing technology for spinal applications across the U.S. Feb 12, 2016
National Government Services Issues Coverage for MIS SI Joint Fusion
National Government Services issued a positive local coverage determination for MIS SI joint fusion, including SI-BONE’s iFuse procedure, effective 4/1/16. Feb 12, 2016
Wenzel Spine Receives FDA 510(k) Clearance for VariLift-LX
Wenzel Spine received FDA 510(k) clearance to market VariLift®-LX as a lumbar interbody fusion device for standalone use. Feb 11, 2016
Regentis Biomaterials Raises $15MM for U.S. Pivotal Clinical Trial
Regentis Biomaterials closed a US $15MM Series D investment round. Funds will primarily support a pivotal U.S. clinical trial of GelrinC®, a cell-free implant for the treatment of articular knee cartilage injuries. Feb 10, 2016
MX Orthopedics Receives FDA Clearance for dynaMX Compression Staple
MX Orthopedics received FDA 510(k) clearance to market the dynaMX™ Compression Staple, a superelastic Nitinol-based device. Feb 10, 2016
